Saturday, Apr 01, 2023
×
Outlook.com
×

Covaxin

Covid-19 vaccine for kids aged 5-12 years.(Representational image)

Covovax Booster Dose For Covid-19, Its Efficacy Rate And How Does It Work? All You Need To Know

Based on three phases of clinical trials, the overall efficacy rate of Covovax is estimated at around 89 per cent.

17 January 2023

Centre said it's not liable for Covid-19 vaccine-related deaths

Government Not Liable For Vaccine-Related Deaths: Centre To Supreme Court

The Union government was responding to petition filed by parents of two women who allegedly died after receiving Covishield vaccines, as per reports.

29 November 2022

COVAXIN is Indias indigenous COVID-19 vaccine candidate developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Government Rubbishes Reports On Approval For Covaxin Due To Political Pressure

Before Covaxin was approved for restricted emergency use in January 2021, the Subject Expert Committee reviewed the data on safety and immunogenicity of the vaccine and recommended for grant of permission for restricted use...

17 November 2022

Imports of Covid-19 Vaccines Exempted From Customs Duty Till March 31

Imports of Covid-19 Vaccines Exempted From Customs Duty Till March 31

The government had, in April 2021, first exempted Covid-19 vaccines from 10 per cent customs duty

16 January 2023

Covaxin (Representative image)

No External Pressure To Accelerate Development Of Covaxin-Bharat Biotech

Refuting some media reports around the approvals for Covaxin, the vaccine maker said it condemns the "targeted narrative" against the vaccine put forth by a select few individuals and groups who have no expertise in vaccines...

17 November 2022

COVAXIN

50 mn Doses Of Covaxin Set To Expire Early 2023 Due To Poor Off Take

Due to lack of product demand, Production stoppage of Covaxin- a two dose jab, was initiated by Bharat Biotech earlier this year, though the vaccine maker has established manufacturing to reach an annualised capacity of 1...

06 November 2022

COVID pandemic

Covishield Immune Responses Against Covid Variants Higher Than Covaxin: Study

Neutralising antibody responses against the SARS-COV-2 virus and its variants of concern (VoC) are higher among Covishield recipients than those who took the indigenously made Covaxin, according to a multi-centre study.

07 January 2023

Advertisement

Bharat Biotech Expects Regulator’s Nod For Intranasal Covid-19 Vaccine In August

Vaccine manufacturer Bharat Biotech is expecting to receive clearance for its intranasal covid-19 vaccine in the month of August.

02 August 2022

Advertisement
29 July 2022
Immunity From Natural Covid Infection, Vaccines Not Absolute: Minister of State for Health

Immunity From Natural Covid Infection, Vaccines Not Absolute: Minister of State for Health

Out of 88 post-vaccination SARS-CoV-2 breakthrough infections, 90.91 per cent were symptomatic cases and the remaining 9.09 per cent were...


08 July 2022
NTAGI Panel Recommends Use Of Covid-19 Vaccines Corbevax, Covaxin For Children Aged 5-12 Years

NTAGI Panel Recommends Use Of Covid-19 Vaccines Corbevax, Covaxin For Children Aged 5-12 Years

NTAGI's Standing Technical Sub-Committee (STSC), however, couldn’t arrive at a decision on introducing Corbevax and Covaxin in the vaccination programme.


17 June 2022
Covaxin Safe And Highly Effective In Children Between 2-18 Years Of Age, Shows Study

Covaxin Safe And Highly Effective In Children Between 2-18 Years Of Age, Shows Study

A study published in The Lancet Infectious Diseases medical journal shows that the vaccine 'induced higher neutralising antibody responses than those...


15 June 2022
Covaxin Booster Dose Enhances Vaccine Effectiveness Against Delta, Omicron Variants, Says ICMR Study

Covaxin Booster Dose Enhances Vaccine Effectiveness Against Delta, Omicron Variants, Says ICMR Study

"The virus shedding and viral organ load were considerably reduced in both the two dose and three-dose immunised animals indicating the vaccine efficacy...


24 May 2022
FDA Lifts Hold On Covaxin's Clinical Trials In US

FDA Lifts Hold On Covaxin's Clinical Trials In US

FDA had earlier implemented a temporary pause on Covaxin trials, following the WHO's observations on Covaxin manufacturing plants in India.


Advertisement

11 May 2022
Biological E Seeks EUA For Corbevax As Booster In Adults Vaccinated With Covishield, Covaxin

Biological E Seeks EUA For Corbevax As Booster In Adults Vaccinated With Covishield, Covaxin

According to the EUA application submitted to DCGI, Biological E in a phase-3 placebo-controlled clinical study, based on the drug regulator's nod, has...


28 April 2022
Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid EUL Cancellation, Says MEA

Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid EUL Cancellation, Says MEA

Although WHO maintained that the vaccine is effective and there is no safety concern, it has recommended that countries using the vaccine take action as...


28 April 2022
COVID-19: NTAGI May Recommend Vaccination For 5-12 Age Group On Friday

COVID-19: NTAGI May Recommend Vaccination For 5-12 Age Group On Friday

Corbevax is currently being used to inoculate children against COVID-19 in the age group of 12 to 14 years.


26 April 2022
DCGI Grants EUA To Corbevax For Those Aged 5-12, Covaxin For 6-12 Age Group

DCGI Grants EUA To Corbevax For Those Aged 5-12, Covaxin For 6-12 Age Group

The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase. Vaccination of...


26 April 2022
Covid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: Reports

Covid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: Reports

Bharat Biotech's Covaxin cleared for 6-12 age group by drugs regulator DCGI, as per media reports


11 April 2022
Epygen Biotech Gets Funding From Govt For New Affordable Covid Vaccine

Epygen Biotech Gets Funding From Govt For New Affordable Covid Vaccine

The company said it has received funding to initiate the Phase I and Phase II trials of an indigenous affordable Receptor-Binding Domain (RBD) based vaccine...


Advertisement

10 April 2022
SII To Give Free Covishield Vials To Pvt Vaccination Centres To Compensate For Price Difference

SII To Give Free Covishield Vials To Pvt Vaccination Centres To Compensate For Price Difference

Vaccine majors SII and Bharat Biotech on Saturday said they have decided to cut the prices of the precaution dose of their respective COVID-19 vaccines to Rs...


09 April 2022
Covaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: Study

Covaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: Study

The study by the ICMR and Covaxin manufacturer Bharat Biotech was conducted in January and the findings were published in the Journal of Travel Medicine on...


04 April 2022
No Impact Of WHO Action On Covaxin, Have Not Supplied To Any UN Agency: Bharat Biotech

No Impact Of WHO Action On Covaxin, Have Not Supplied To Any UN Agency: Bharat Biotech

Citing good manufacturing practices deficiencies, the World Health Organization (WHO) on April 2 confirmed the suspension of supply of Covaxin


03 April 2022
Who Suspends UN Supply Of Bharat Biotech's Covaxin Vaccine For Covid-19

Who Suspends UN Supply Of Bharat Biotech's Covaxin Vaccine For Covid-19

The WHO asked countries that have received the vaccine to take appropriate actions, according to the statement, but did not specify what the appropriate...


03 April 2022
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech

WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech

The WHO said the Bharat Biotech vaccine is effective and no safety concerns exist, but the suspension of production for export will result in the interruption...


16 March 2022
Bharat Biotech Enters Into Partnership With Biofabri For TB Vaccine

Bharat Biotech Enters Into Partnership With Biofabri For TB Vaccine

Bharat Biotech Chairman and Managing Director Krishna Ella said, "We are proud to announce this partnership with BioFabri, where MTBVAC can become a global TB...


Advertisement
Advertisement
Advertisement
Advertisement
Advertisement